Tenax Therapeutics (TENX) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts TENX Hot Sheet
Join SI Premium – FREE
Tenax Therapeutics (NASDAQ: TENX) reported Q3 EPS of ($0.15), $0.02 better than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Tenax Therapeutics (TENX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- e.l.f. Beauty, Inc. (ELF) Tops Q2 EPS by 64c, Beats on Revenue; Offers FY27 Guidance
- Dutch Bros Inc. (BROS) Tops Q3 EPS by 1c; offers guidance
- Aflac (AFL) Tops Q3 EPS by 63c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
